UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 147

Sortiert nach

A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction

Nature communications, 2020-08, Vol.11 (1), p.4198-4198, Article 4198

2020

Volltextzugriff (PDF)

Treatment Trials for Post-Lyme Disease Symptoms Revisited

The American journal of medicine, 2013-08, Vol.126 (8), p.665-669

2013

Volltextzugriff (PDF)

Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance

Proceedings of the National Academy of Sciences - PNAS, 2013-08, Vol.110 (35), p.14420-14425

2013

Volltextzugriff (PDF)

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

Clinical infectious diseases, 2006-11, Vol.43 (9), p.1089-1134

2006

Volltextzugriff (PDF)

Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design

Scientific reports, 2021-02, Vol.11 (1), p.2751-2751, Article 2751

2021

Volltextzugriff (PDF)

Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak

Science (American Association for the Advancement of Science), 2016-03, Vol.351 (6277), p.1078-1083

2016

Volltextzugriff (PDF)

Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection

Infection and immunity, 2018-08, Vol.86 (8)

2018

Volltextzugriff (PDF)

Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model

Vaccine, 2020-02, Vol.38 (10), p.2333-2339

2020

Volltextzugriff (PDF)

IgA as a potential candidate for enteric monoclonal antibody therapeutics with improved gastrointestinal stability

Vaccine, 2020-11, Vol.38 (47), p.7490-7497

2020

Volltextzugriff (PDF)

Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration

Journal of pharmaceutical sciences, 2020-01, Vol.109 (1), p.407-421

2020

Volltextzugriff (PDF)

Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants

Frontiers in immunology, 2022-09, Vol.13, p.995412-995412

2022

Volltextzugriff (PDF)

Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody

The Journal of clinical investigation, 2021-06, Vol.131 (11), p.1-12

2021

Volltextzugriff (PDF)

Anti-OspA DNA-Encoded Monoclonal Antibody Prevents Transmission of Spirochetes in Tick Challenge Providing Sterilizing Immunity in Mice

The Journal of infectious diseases, 2019-03, Vol.219 (7), p.1146-1150

2019

Volltextzugriff (PDF)

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

The New England journal of medicine, 2001-07, Vol.345 (2), p.85-92

2001

Volltextzugriff (PDF)

A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis

Scientific reports, 2022-06, Vol.12 (1), p.9403-9403, Article 9403

2022

Volltextzugriff (PDF)

Pre-exposure Prophylaxis With OspA-Specific Human Monoclonal Antibodies Protects Mice Against Tick Transmission of Lyme Disease Spirochetes

The Journal of infectious diseases, 2016-07, Vol.214 (2), p.205-211

2016

Volltextzugriff (PDF)

Association of Immune Response to Endothelial Cell Growth Factor With Early Disseminated and Late Manifestations of Lyme Disease but Not Posttreatment Lyme Disease Syndrome

Clinical infectious diseases, 2015-12, Vol.61 (11), p.1703-1706

2015

Volltextzugriff (PDF)

Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms

Brain, behavior, and immunity, 2010-08, Vol.24 (6), p.1018-1024

2010

Volltextzugriff (PDF)

Correction for Giuntini et al., "Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection"

Infection and immunity, 2018-12, Vol.86 (12)

2018

Volltextzugriff (PDF)

Taking a Bite Out of Vector-Transmitted Infectious Diseases

The New England journal of medicine, 2007-06, Vol.356 (25), p.2567-2569

2007

Volltextzugriff (PDF)

Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants

Gut microbes, 2021-01, Vol.13 (1), p.1

2021

Volltextzugriff (PDF)

Reply to Blair et al.: Dose-dependent effects and oxidative stress responses in antibiotic tolerance in Salmonella typhimurium

Proceedings of the National Academy of Sciences - PNAS, 2013-11, Vol.110 (48), p.E4570-E4570

2013

Volltextzugriff (PDF)

Highly Specific Mouse Anti-Joining Chain of Human Immunoglobulin A

Monoclonal antibodies in immunodiagnosis and immunotherapy, 2020-12, Vol.39 (6), p.228

2020

Volltextzugriff (PDF)

Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions

Journal of molecular recognition, 2017-05, Vol.30 (5), p.np-n/a

2017

Volltextzugriff (PDF)

CD14 Mediates Cross Talk between Mononuclear Cells and Fibroblasts for Upregulation of Matrix Metalloproteinase 9 by Borrelia burgdorferi

Infection and Immunity, 2007-06, Vol.75 (6), p.3062-3069

2007

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(131)

Publikationsform

Sprache

Englisch
(146)
Japanisch
(11)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(87)
Humans
(78)
Life Sciences & Biomedicine
(77)
Biological And Medical Sciences
(40)
Infectious Diseases
(39)
Immunology
(37)
Microbiology
(33)
Animals
(30)
Borrelia Burgdorferi
(27)
Lyme Disease
(27)
Medical Sciences
(27)
Male
(20)
Adult
(19)
Female
(19)
Fundamental And Applied Biological Sciences. Psychology
(17)
General & Internal Medicine
(17)
Medicine, General & Internal
(17)
Infections
(15)
Antibiotics
(14)
Aged
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction

Treatment Trials for Post-Lyme Disease Symptoms Revisited

Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design

Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak

Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection

Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model

IgA as a potential candidate for enteric monoclonal antibody therapeutics with improved gastrointestinal stability

Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration

Mucosal nanobody IgA as inhalable and affordable prophylactic and therapeutic treatment against SARS-CoV-2 and emerging variants

Blocking Borrelia burgdorferi transmission from infected ticks to nonhuman primates with a human monoclonal antibody

Anti-OspA DNA-Encoded Monoclonal Antibody Prevents Transmission of Spirochetes in Tick Challenge Providing Sterilizing Immunity in Mice

Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease

A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis

Pre-exposure Prophylaxis With OspA-Specific Human Monoclonal Antibodies Protects Mice Against Tick Transmission of Lyme Disease Spirochetes

Association of Immune Response to Endothelial Cell Growth Factor With Early Disseminated and Late Manifestations of Lyme Disease but Not Posttreatment Lyme Disease Syndrome

Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms

Correction for Giuntini et al., "Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection"

Taking a Bite Out of Vector-Transmitted Infectious Diseases

Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants

Reply to Blair et al.: Dose-dependent effects and oxidative stress responses in antibiotic tolerance in Salmonella typhimurium

Highly Specific Mouse Anti-Joining Chain of Human Immunoglobulin A

Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions

CD14 Mediates Cross Talk between Mononuclear Cells and Fibroblasts for Upregulation of Matrix Metalloproteinase 9 by Borrelia burgdorferi

Suchergebnisse filtern